Tin tức & Cập nhật
Xem bài viết Ung thư
Xem
Chỉ hiển thị Multimedia

PATINA: 1L palbociclib combo extends PFS in HR+, HER2+ mBC
11 Mar 2026
bởiKanas Chan
Addition of palbociclib to maintenance therapy yielded a median progression-free survival (mPFS) approaching 4 years, representing an effective first-line (1L) treatment for patients with hormone receptor–positive (HR+), HER2-positive (HER2+) metastatic breast cancer (mBC), according to the phase III PATINA trial.
11 Mar 2026

Stool-based microbial test transforms colon cancer detection
05 Mar 2026
bởiKanas Chan
A stool-based microbial diagnostic test outperforms faecal immunochemical test (FIT) in detecting colorectal cancer (CRC) or advanced adenoma (polyps) in a study conducted in Hong Kong, Singapore and Japan.
05 Mar 2026






